Delivery of alprazolam, estazolam, midazolam or triazolam throughan inhalation route
Details for Australian Patent Application No. 2002310085 (hide)
International Classifications
Event Publications
19 December 2002 Complete Application Filed
Priority application(s): 60/294,203 24.05.01 US; 60/317,479 05.09.01 US; 60/345,876 09.11.01 US
8 May 2003 Application Open to Public Inspection
Published as AU-B-2002310085
15 December 2005 Assignment before Grant
Alexza Molecular Delivery Corporation The application has been assigned to Alexza Pharmaceuticals, Inc.
4 September 2008 Application Accepted
Published as AU-B-2002310085
2 October 2008 Application for Amendment
The nature of the amendment is: Amend the invention title to read from Delivery of alprazolam, estazolam, midazolam or triazolam throughan inhalation route To: Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route. Address for service in Australia - Davies Collison Cave Level 15 1 Nicholson Street Melbourne VIC 3000
22 January 2009 Amendment Made
The nature of the amendment is: Amend the invention title to read Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
29 January 2009 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002310086-Delivery of erectile dysfunction drugs through an inhalation route
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser